- Report
- October 2023
- 206 Pages
Global
From €4786EUR$4,950USD£4,111GBP
- Report
- March 2024
- 196 Pages
Global
From €3262EUR$3,374USD£2,802GBP
€3624EUR$3,749USD£3,113GBP
- Report
- April 2024
- 194 Pages
Global
From €4786EUR$4,950USD£4,111GBP
- Report
- October 2023
- 150 Pages
Global
From €4689EUR$4,850USD£4,028GBP
- Report
- February 2024
- 180 Pages
Global
From €4737EUR$4,900USD£4,069GBP
- Report
- August 2020
Global
From €5114EUR$5,290USD£4,393GBP
The Transplant HLA Typing market within the In Vitro Diagnostics industry is focused on the development of tests and technologies used to identify and match human leukocyte antigens (HLA) for organ transplantation. HLA typing is used to determine the compatibility of donor and recipient tissue, and is a critical step in the transplantation process. Companies in this market develop and manufacture a range of products, including reagents, kits, and instruments used to identify and match HLA types. These products are used in clinical laboratories, hospitals, and research institutions.
Some companies in the Transplant HLA Typing market include Bio-Rad Laboratories, Immucor, Thermo Fisher Scientific, QIAGEN, and GenDx. Show Less Read more